These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1997100)

  • 1. Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes.
    Niimi S; Nakagawa K; Yokota J; Tsunokawa Y; Nishio K; Terashima Y; Shibuya M; Terada M; Saijo N
    Br J Cancer; 1991 Feb; 63(2):237-41. PubMed ID: 1997100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genes].
    Niimi S; Yokoyama S; Terashima Y; Saijo N
    Hum Cell; 1991 Mar; 4(1):33-7. PubMed ID: 1888702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of anticancer drugs in NIH3T3' cells transfected with oncogenes accompanied by pSV2neo vector.
    Gao XS; Asaumi J; Kawasaki S; Nishikawa K; Kuroda M; Takeda Y; Hiraki Y; Ihara M; Ohnishi T
    Anticancer Res; 1995; 15(5B):1911-4. PubMed ID: 8572577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity of NIH3T3 cells transformed by H-ras gene to DNA-topoisomerase-I inhibitors.
    Ohira T; Nishio K; Kanzawa F; Ishida T; Ohe Y; Arioka H; Funayama Y; Ogasawara H; Kato H; Saijo N
    Int J Cancer; 1996 Sep; 67(5):702-8. PubMed ID: 8782662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
    Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of myc overexpression on the phenotypic properties of Chinese hamster lung cells resistant to antitumor agents.
    Delaporte C; Larsen AK; Dautry F; Jacquemin-Sablon A
    Exp Cell Res; 1991 Dec; 197(2):176-82. PubMed ID: 1720389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity pattern of normal and Ha-ras transformed NIH3T3 fibroblasts to antineoplastic drugs.
    Toffoli G; Viel A; Tumiotto L; Buttazzi P; Biscontin G; Boiocchi M
    Tumori; 1989 Oct; 75(5):423-8. PubMed ID: 2690431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of human larynx carcinoma cells to cisplatin, gamma-irradiation and methotrexate does not involve overexpression of c-myc or c-Ki-ras oncogenes.
    Osmak M; Beketić-Oresković L; Matulić M; Sorić J
    Mutat Res; 1993 Nov; 303(3):113-20. PubMed ID: 7694127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged inhibition by X-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc.
    Wang Y; Iliakis G
    Cancer Res; 1992 Feb; 52(3):508-14. PubMed ID: 1732037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple effects on drug-sensitivity, genome stability and malignant potential by combinations of h-ras, C-myc and mutant p53 gene overexpression.
    Huang A; Jin H; Taylor W; Wright J
    Int J Oncol; 1995 Jul; 7(1):57-63. PubMed ID: 21552806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of transfection with the oncogenes H-ras and c-myc on the radiosensitivity of a mink epithelial cell line.
    Russell J; Khan MZ; Kerr DJ; Spandidos DA
    Radiat Res; 1992 Apr; 130(1):113-6. PubMed ID: 1561309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of cytotoxicity of chemotherapeutic drugs by activated H-ras.
    Fan J; Banerjee D; Stambrook PJ; Bertino JR
    Biochem Pharmacol; 1997 Apr; 53(8):1203-9. PubMed ID: 9175726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipain-induced suppression of oncogene expression in H-ras-transformed NIH3T3 cells.
    Cox LR; Motz J; Troll W; Garte SJ
    Cancer Res; 1991 Sep; 51(18):4810-4. PubMed ID: 1893373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in effects of oncogenes on sensitivity to anticancer drugs.
    Hamamoto T; Suzuki K; Sasaki H; Ichikawa M; Kodama S; Watanabe M
    J Radiat Res; 2005 Jun; 46(2):197-203. PubMed ID: 15988138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple fractions of gamma rays do not induce overexpression of c-myc or c-Ki-ras oncogenes in human cervical carcinoma cells.
    Osmak M; Sorić J; Matulić M
    Neoplasma; 1993; 40(6):359-62. PubMed ID: 8289968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-transformation of non-transformed hybrids between c-myc-activating mouse plasmacytoma cells and normal fibroblasts by transfection with activated c-Ha-ras but not c-myc.
    Satoh C; Oikawa T; Kondoh N; Kuzumaki N
    Int J Cancer; 1991 Sep; 49(3):403-8. PubMed ID: 1917139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional interaction of p53 with HPV18 E6, c-myc and H-ras in 3T3 cells.
    Chen TM; Defendi V
    Oncogene; 1992 Aug; 7(8):1541-7. PubMed ID: 1321402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic effect of the v-myc oncogene with H-ras on radioresistance.
    McKenna WG; Weiss MC; Endlich B; Ling CC; Bakanauskas VJ; Kelsten ML; Muschel RJ
    Cancer Res; 1990 Jan; 50(1):97-102. PubMed ID: 2403420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to 195mPt-radiolabeled cis-diaminedichloroplatinum (II) of SHOK cells transfected with various oncogenes.
    Kinashi Y; Akaboshi M; Masunaga S; Ono K; Watanabe M
    Radiat Med; 1998; 16(4):233-7. PubMed ID: 9814416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of murine LTA cells to oncogene--mediated progression from tumorigenic to metastatic phenotype.
    Tuck AB; Wilson SM; Chambers AF
    Anticancer Res; 1990; 10(6):1507-14. PubMed ID: 2285224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.